Q: What type of rosacea concerns is Calming intended for?
A: Calming is particularly focused on rosacea involving inflammatory bumps, pustules, and accompanying redness. Rosacea can appear differently from person to person, so our healthcare provider will determine whether this formulation matches your symptoms.
Q: Why are ivermectin and metronidazole both included?
A: They have different pharmacologic properties but are both used in rosacea care. Ivermectin has anti-inflammatory and antiparasitic activity, while metronidazole provides antimicrobial and anti-inflammatory activity.
Q: Will Calming completely remove facial redness?
A: Not necessarily. Redness caused partly by inflammation may improve as rosacea is managed, but persistent redness and visible blood vessels can have different underlying mechanisms and may require other treatment approaches.
Q: What role does azelaic acid play?
A: Azelaic acid provides anti-inflammatory activity and is used in rosacea treatment, particularly for inflammatory papules and pustules. It can also influence pigmentation, which may be relevant when inflammation leaves uneven-looking skin tone.
Q: Why is niacinamide included if the other ingredients treat rosacea?
A: Rosacea-prone skin can also be sensitive and have barrier concerns. Niacinamide helps support barrier function and moisture retention without being presented as the primary medication treating rosacea.
Q: When should treatment be reassessed?
A: An initial period of approximately 8–12 weeks may be used to evaluate changes in inflammatory lesions, redness, and skin tolerance. Our healthcare provider can then determine whether continued or modified treatment is appropriate.
